Parastoo Khoshakhlagh is the founder of GC Therapeutics. GC Therapeutics has raised $75M in total funding. Latest round: Series A.
Parastoo Khoshakhlagh, Ph.D., is the CEO and Co-Founder of GC Therapeutics, a biopharmaceutical company spun out of George Church's lab at Harvard Medical School and the Wyss Institute. She has led the company since its founding in April 2019, overseeing its official launch in 2024 with $75 million in total capital. Her work leverages a syn-bio platform combining gene editing, machine learning, and transcription factor screening to turn iPSCs into 'SuperCells'.
Full founder directory · Investor directory · Company funding database · Fundraising library